Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Bioevaluation of novel anti-biofilm coatings based on PVP/Fe3O4 nanostructures and 2-((4-ethylphenoxy)methyl)-N- (arylcarbamothioyl)benzamides.

Limban C, Missir AV, Grumezescu AM, Oprea AE, Grumezescu V, Vasile BS, Socol G, Trușcă R, Caproiu MT, Chifiriuc MC, Gălățeanu B, Costache M, Morușciag L, Pîrcălăbioru G, Nuță DC.

Molecules. 2014 Aug 12;19(8):12011-30. doi: 10.3390/molecules190812011.

2.

Optimized anti-pathogenic agents based on core/shell nanostructures and 2-((4-ethylphenoxy)ethyl)-N-(substituted-phenylcarbamothioyl)-benzamides.

Limban C, Grumezescu AM, Saviuc C, Voicu G, Predan G, Sakizlian R, Chifiriuc MC.

Int J Mol Sci. 2012 Oct 1;13(10):12584-97. doi: 10.3390/ijms131012584.

3.

Efficiency of vanilla, patchouli and ylang ylang essential oils stabilized by iron oxide@C14 nanostructures against bacterial adherence and biofilms formed by Staphylococcus aureus and Klebsiella pneumoniae clinical strains.

Bilcu M, Grumezescu AM, Oprea AE, Popescu RC, Mogoșanu GD, Hristu R, Stanciu GA, Mihailescu DF, Lazar V, Bezirtzoglou E, Chifiriuc MC.

Molecules. 2014 Nov 4;19(11):17943-56. doi: 10.3390/molecules191117943.

4.

In vitro evaluation of anti-pathogenic surface coating nanofluid, obtained by combining Fe3O4/C12 nanostructures and 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides.

Anghel I, Limban C, Grumezescu AM, Anghel AG, Bleotu C, Chifiriuc MC.

Nanoscale Res Lett. 2012 Sep 19;7(1):513. doi: 10.1186/1556-276X-7-513.

5.

Synthesis, spectroscopic properties and antipathogenic activity of new thiourea derivatives.

Limban C, Marutescu L, Chifiriuc MC.

Molecules. 2011 Sep 6;16(9):7593-607. doi: 10.3390/molecules16097593.

6.

Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus.

Singh V, Arora V, Alam MJ, Garey KW.

Antimicrob Agents Chemother. 2012 Aug;56(8):4360-4. doi: 10.1128/AAC.00544-12.

7.

Functionalized magnetite silica thin films fabricated by MAPLE with antibiofilm properties.

Mihaiescu DE, Cristescu R, Dorcioman G, Popescu CE, Nita C, Socol G, Mihailescu IN, Grumezescu AM, Tamas D, Enculescu M, Negrea RF, Ghica C, Chifiriuc C, Bleotu C, Chrisey DB.

Biofabrication. 2013 Mar;5(1):015007. doi: 10.1088/1758-5082/5/1/015007.

PMID:
23254399
8.

Control of bacterial biofilms with marine alkaloid derivatives.

Huigens RW 3rd, Ma L, Gambino C, Moeller PD, Basso A, Cavanagh J, Wozniak DJ, Melander C.

Mol Biosyst. 2008 Jun;4(6):614-21. doi: 10.1039/b719989a.

PMID:
18493660
9.

Fabrication of magnetite-based core-shell coated nanoparticles with antibacterial properties.

Grumezescu AM, Cristescu R, Chifiriuc MC, Dorcioman G, Socol G, Mihailescu IN, Mihaiescu DE, Ficai A, Vasile OR, Enculescu M, Chrisey DB.

Biofabrication. 2015 Mar 23;7(1):015014. doi: 10.1088/1758-5090/7/1/015014.

PMID:
25797361
10.

Activity of N-acetyl-L-cysteine against biofilm of Staphylococcus aureus and Pseudomonas aeruginosa on orthopedic prosthetic materials.

Drago L, De Vecchi E, Mattina R, Romanò CL.

Int J Artif Organs. 2013 Jan;36(1):39-46. doi: 10.5301/ijao.5000135.

PMID:
23280076
11.

In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.

Gupta S, Agarwal S, Sahoo DR, Muralidharan S.

Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):569-71. doi: 10.4103/0377-4929.85095.

12.

Anti-biofilm and anti-adherence activity of Glm-U inhibitors.

Suman E, D'souza SJ, Jacob P, Sushruth MR, Kotian MS.

Indian J Med Sci. 2011 Sep;65(9):387-92. doi: 10.4103/0019-5359.108954.

13.

Bacterial adhesion forces with substratum surfaces and the susceptibility of biofilms to antibiotics.

Muszanska AK, Nejadnik MR, Chen Y, van den Heuvel ER, Busscher HJ, van der Mei HC, Norde W.

Antimicrob Agents Chemother. 2012 Sep;56(9):4961-4. doi: 10.1128/AAC.00431-12.

14.

The antimicrobial effect of Octenidine-dihydrochloride coated polymer tracheotomy tubes on Staphylococcus aureus and Pseudomonas aeruginosa colonisation.

Zumtobel M, Assadian O, Leonhard M, Stadler M, Schneider B.

BMC Microbiol. 2009 Jul 25;9:150. doi: 10.1186/1471-2180-9-150.

15.

Regioselective synthesis and antimicrobial screening of novel ketocarbazolodispiropyrrolidine derivatives.

Periyasami G, Raghunathan R, Surendiran G, Mathivanan N.

Eur J Med Chem. 2009 Mar;44(3):959-66. doi: 10.1016/j.ejmech.2008.07.009.

PMID:
18722036
16.

[Experimental research in vitro on antibacterial property and biocompatibility of silver-containing hydroxyapatite coating].

Ruan H, Liu J, Fan C, Zheng X, Chen Y.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Feb;23(2):226-30. Chinese.

PMID:
19275110
17.

Biofilm susceptibility to metal toxicity.

Harrison JJ, Ceri H, Stremick CA, Turner RJ.

Environ Microbiol. 2004 Dec;6(12):1220-7.

PMID:
15560820
18.

Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101.

Jiang P, Li J, Han F, Duan G, Lu X, Gu Y, Yu W.

PLoS One. 2011 Apr 7;6(4):e18514. doi: 10.1371/journal.pone.0018514.

19.

Photodynamic antibacterial and antibiofilm activity of RLP068/Cl against Staphylococcus aureus and Pseudomonas aeruginosa forming biofilms on prosthetic material.

Vassena C, Fenu S, Giuliani F, Fantetti L, Roncucci G, Simonutti G, Romanò CL, De Francesco R, Drago L.

Int J Antimicrob Agents. 2014 Jul;44(1):47-55. doi: 10.1016/j.ijantimicag.2014.03.012.

PMID:
24933446
20.

Novel N-phenylcarbamothioylbenzamides with anti-inflammatory activity and prostaglandin E2 inhibitory properties.

Limban C, Missir AV, Fahelelbom KM, Al-Tabakha MM, Caproiu MT, Sadek B.

Drug Des Devel Ther. 2013 Aug 28;7:883-92. doi: 10.2147/DDDT.S46691.

Items per page

Supplemental Content

Support Center